S100A7 attenuates immunotherapy by enhancing immunosuppressive tumor microenvironment in lung squamous cell carcinoma

Signal Transduct Target Ther. 2022 Oct 21;7(1):368. doi: 10.1038/s41392-022-01196-4.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Non-Small-Cell Lung*
  • Carcinoma, Squamous Cell* / genetics
  • Carcinoma, Squamous Cell* / pathology
  • Carcinoma, Squamous Cell* / therapy
  • Humans
  • Immunotherapy
  • Lung / pathology
  • Lung Neoplasms* / genetics
  • Lung Neoplasms* / pathology
  • Lung Neoplasms* / therapy
  • S100 Calcium Binding Protein A7
  • Tumor Microenvironment / genetics

Substances

  • S100A7 protein, human
  • S100 Calcium Binding Protein A7